Stock PTGX PROTAGONIST THERAPEUTICS, INC.
Add to a list

Sector valuations Protagonist Therapeutics, Inc.

Equities

PTGX

US74366E1029

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 16:00:00 2026-04-15 EDT 		5-day change 1st Jan Change
105.44 USD +0.69% Intraday chart for Protagonist Therapeutics, Inc. +3.28% +20.72%
04-15 Truist Raises Price Target on Protagonist Therapeutics to $121 From $110, Keeps Buy Rating MT
03-30 Protagonist Therapeutics Insider Sold Shares Worth $2,520,000, According to a Recent SEC Filing MT
Main competitors
Add to a list

0 selected

To use this feature you must be a member
Log inSign up
 P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
PROTAGONIST THERAPEUTICS, INC. Stock Protagonist Therapeutics, Inc.
34.95x - -0.14x14.05x29.4x30.53x-.--% 6.73B
LONZA GROUP AG Stock Lonza Group AG
32.23x3.81x1.5x5.62x17.42x24.59x1.02% 47.73B
BEONE MEDICINES AG Stock BeOne Medicines AG
56.03x7.21x0.47x4.84x32.53x41.02x-.--% 35.48B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
21.57x3.89x5.95x2.46x10.6x16.15x-.--% 29.9B
REVOLUTION MEDICINES, INC. Stock Revolution Medicines, Inc.
-18.87x25.99x-0.61x512.08x-17.31x-17.24x-.--% 30.23B
CELLTRION, INC. Stock Celltrion, Inc.
33.19x2.41x1.16x8.17x21.02x25.29x0.38% 28.75B
ASCENDIS PHARMA A/S Stock Ascendis Pharma A/S
50.52x170.76x-0.24x9.04x28.29x37.44x-.--% 14.93B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
30.39x15.48x2.53x4.93x22.45x23.51x-.--% 14.81B
EUROFINS SCIENTIFIC SE Stock Eurofins Scientific SE
23.07x2.52x0.7x2.01x8.83x13.77x1.1% 14.42B
IONIS PHARMACEUTICALS, INC. Stock Ionis Pharmaceuticals, Inc.
-18.77x-52.22x-0.26x14.85x-20.54x-19.1x-.--% 12.69B
ABIVAX Stock Abivax
-29.61x39.08x1.13x3029.6x-33.2x-29.67x-.--% 9.68B
PRAXIS PRECISION MEDICINES, INC. Stock Praxis Precision Medicines, Inc.
-22.94x8.51x-2.06x1413.45x-19.42x-19.19x-.--% 9.47B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
46.68x4.24x0.27x7.47x20.92x23.01x0.55% 9.15B
TEMPUS AI, INC. Stock Tempus AI, Inc.
-29.74x20.91x-1.64x5.97x148.45x-281.5x-.--% 10.11B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
26.27x2.59x-0.08x2.72x10.68x12.98x-.--% 8.91B
QIAGEN N.V. Stock Qiagen N.V.
18.85x2.28x1.32x4.16x11.2x14.11x0.32% 8.61B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
17.53x0.93x-0.54x1.43x7.31x8.09x-.--% 8.9B
PHARMARON BEIJING CO., LTD. Stock Pharmaron Beijing Co., Ltd.
27.49x3.22x1.28x3.41x14.14x20.69x0.81% 7.75B
Average 16.60x 15.39x 0.60x 280.35x 16.26x -4.20x 0.23% 17.13B
Weighted average by Cap. 21.01x 14.42x 1.02x 193.66x 15.43x 5.68x 0.29%
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. PTGX Stock
  4. Sector Protagonist Therapeutics, Inc.
  5. Sector valuations

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

MarketScreener
United-States
MarketScreener Canada
Canada

MIDDLE EAST

MarketScreener Saudi Arabia
Saudi Arabia
MarketScreener UAE Emirates
United Arab Emirates

EUROPE

Zonebourse
France
MarketScreener Deutschland
Deutschland
Zonebourse Suisse
Suisse
MarketScreener Schweiz
Schweiz
MarketScreener Italia
Italia
MarketScreener Österreich
Österreich
MarketScreener België
België
MarketScreener Nederland
Nederland
MarketScreener España
España
MarketScreener Sverige
Sverige
MarketScreener UK
United Kingdom

APAC

MarketScreener Australia
Australia
MarketScreener India
India
MarketScreener Hong Kong
Hong Kong

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition